Inhibikase Therapeutics Inc (IKT)
EBITDA
-$19.59M
Quarterly · Period ending: · USD
IKT EBITDA
Latest reported-$19.59Mperiod ending
Latest reported-$19.59Mperiod ending
IKT Quarterly EBITDA ($0.00 → -$19.59M)
Quarterly EBITDA
High-resolution chart · PNG
IKT ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -19,591,231 | |
| -16,380,840 | |
| -13,133,457 | |
| -13,237,513 | |
| -11,166,540 | |
| -15,750,216 | |
| -12,126,010 | |
| -5,771,498 | |
| -4,953,039 | |
| -4,643,067 | |
| -4,171,372 | |
| -4,588,616 | |
| -5,618,762 | |
| -4,472,735 | |
| -4,274,015 | |
| -4,492,882 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,259,072 | |
| 0 | |
| 53,912 | |
| 0 |